Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
Did you miss last night's "Mad Money" on CNBC? If so, here are Jim Cramer's top takeaways for today's trading.
Harman International (HAR) : Cramer sat down with Dinesh Paliwal, chairman and CEO of Harman International (HAR) , the auto infotainment maker that today announced it is being acquired by Samsung (SSNLF) for $112 a share -- a 25% premium from where shares opened for trading.
Paliwal said that the technological transformation in cars continues and in today's market, scale matters. When Harman began talking to Samsung, he said, there were so many complementary technologies being developed, from 5G connectivity and high-resolution displays to speech recognition, and there was hardly any overlap.
Under the terms of the deal, Harman will retain its headquarters and its management team, acting as a subsidiary of Samsung. This gives Harman deep research and development resources, Paliwal added.
Harman is not standing still, as the company has doubled down on cyber security, acquiring another company to help keep its products secure. Cyber attacks can happen to your home, your car or your devices, he said, and Harman takes the challenge seriously.
Cramer's bottom line, "Paliwal saw a lot of things coming and got a lot of things right."
Jim Cramer and Jack Mohr are trimming their Panera (PNRA) position on strength. Read why and what they're telling their members with a free trial membership to the Action Alerts PLUS investment club.
CVS Health (CVS) - Get CVS Health Corporation Report : What the heck happened to this former market darling which, Cramer said, has now become a total dog? After rising from $33 a share in 2011 to a high of $112 last year, shares have now declined a full 33%.
Cramer reminded viewers that CVS is a lot more than just the retail drugstore we see on every corner. The company is also among the largest pharmacy benefit managers, a group that is experiencing a wave of vicious competition.
After purchasing the pharmacy operations of Target (TGT) - Get Target Corporation Report last year, CVS also acquired Omnicare in an effort to bolster its benefit management operations. The latter move proved to be problematic however, as it represented the peak of the pharmacy benefit market.
When the company reported in August, it delivered mixed results but raised its earnings outlook for the year. Then, just three months later, CVS again missed earnings, and this time slashed its guidance. Cramer said this move made CVS management seem clueless in a world where it is seeing increased competition from Walgreens (WAG) and the possible repeal of Obamacare.
Cramer said this once-loved stock is now in the penalty box and he can't recommend it.
CyberArk Software (CYBR) - Get CyberArk Software Ltd. Report : Cramer spoke with Udi Mokady, chairman and CEO of CyberArk, the cybersecurity company that recently posted a 10-cents-a-share earnings beat with better-than-expected revenue, up 37% from the year-ago period. Shares responded with a 6% gain and haven't looked back.
Mokady said that anything that is connected to the Internet is hackable. He said most attacks start small and slowly escalate to privileged administrator accounts, and CyberArk helps prevent those escalations from occurring.
The cybersecurity market is changing, Mokady continued, as CyberArk is now being engaged before attacks happen rather than only after there has been a breach. The company currently has 2,800 customers, but Mokady said he still sees a "green field" opportunity around the world.
"Compliant is not secure," Mokady added, saying that most companies still have a lot of work to do.
Cramer said that CyberArk remains among his favorites in the group.
To read a full recap of "Mad Money" on CNBC, click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
At the time of publication, Cramer's Action Alerts PLUS had a position in PNRA.